Cargando…

Intravenous Immunoglobulin for Severe Protracted Pediatric Guillain–Barre Syndrome: Is Single Dose Adequate?

Detalles Bibliográficos
Autores principales: Madaan, Priyanka, Jauhari, Prashant, Shruthi, NM, Chakrabarty, Biswaroop, Gulati, Sheffali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327712/
https://www.ncbi.nlm.nih.gov/pubmed/30692777
http://dx.doi.org/10.4103/aian.AIAN_100_18
_version_ 1783386521364070400
author Madaan, Priyanka
Jauhari, Prashant
Shruthi, NM
Chakrabarty, Biswaroop
Gulati, Sheffali
author_facet Madaan, Priyanka
Jauhari, Prashant
Shruthi, NM
Chakrabarty, Biswaroop
Gulati, Sheffali
author_sort Madaan, Priyanka
collection PubMed
description
format Online
Article
Text
id pubmed-6327712
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-63277122019-01-28 Intravenous Immunoglobulin for Severe Protracted Pediatric Guillain–Barre Syndrome: Is Single Dose Adequate? Madaan, Priyanka Jauhari, Prashant Shruthi, NM Chakrabarty, Biswaroop Gulati, Sheffali Ann Indian Acad Neurol Letters to the Editor Medknow Publications & Media Pvt Ltd 2019 /pmc/articles/PMC6327712/ /pubmed/30692777 http://dx.doi.org/10.4103/aian.AIAN_100_18 Text en Copyright: © 2006 - 2018 Annals of Indian Academy of Neurology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Letters to the Editor
Madaan, Priyanka
Jauhari, Prashant
Shruthi, NM
Chakrabarty, Biswaroop
Gulati, Sheffali
Intravenous Immunoglobulin for Severe Protracted Pediatric Guillain–Barre Syndrome: Is Single Dose Adequate?
title Intravenous Immunoglobulin for Severe Protracted Pediatric Guillain–Barre Syndrome: Is Single Dose Adequate?
title_full Intravenous Immunoglobulin for Severe Protracted Pediatric Guillain–Barre Syndrome: Is Single Dose Adequate?
title_fullStr Intravenous Immunoglobulin for Severe Protracted Pediatric Guillain–Barre Syndrome: Is Single Dose Adequate?
title_full_unstemmed Intravenous Immunoglobulin for Severe Protracted Pediatric Guillain–Barre Syndrome: Is Single Dose Adequate?
title_short Intravenous Immunoglobulin for Severe Protracted Pediatric Guillain–Barre Syndrome: Is Single Dose Adequate?
title_sort intravenous immunoglobulin for severe protracted pediatric guillain–barre syndrome: is single dose adequate?
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327712/
https://www.ncbi.nlm.nih.gov/pubmed/30692777
http://dx.doi.org/10.4103/aian.AIAN_100_18
work_keys_str_mv AT madaanpriyanka intravenousimmunoglobulinforsevereprotractedpediatricguillainbarresyndromeissingledoseadequate
AT jauhariprashant intravenousimmunoglobulinforsevereprotractedpediatricguillainbarresyndromeissingledoseadequate
AT shruthinm intravenousimmunoglobulinforsevereprotractedpediatricguillainbarresyndromeissingledoseadequate
AT chakrabartybiswaroop intravenousimmunoglobulinforsevereprotractedpediatricguillainbarresyndromeissingledoseadequate
AT gulatisheffali intravenousimmunoglobulinforsevereprotractedpediatricguillainbarresyndromeissingledoseadequate